About Jennifer Ahlstrom
Articles by Jennifer Ahlstrom
When and How to Get Vaccinated After Myeloma TreatmentSep 01, 2020
Honoring a Powerful Myeloma Advocate, Cheryl BoyceSep 01, 2020
The Best Dose of Lenalidomide as Maintenance Therapy in Multiple MyelomaAug 24, 2020
FDA Clears New Use of Kyprolis with Daratumuamb and Dex for Relapsed Multiple Myeloma PatientsAug 20, 2020
How IVig Boosts the Immune System and Kills Multiple MyelomaAug 19, 2020
Why I Care About Minimal Residual Disease (MRD) Testing with Relapsing MyelomaAug 17, 2020
Belantamab Mafodotin Receives FDA Approval for Relapsed Multiple MyelomaAug 06, 2020
Which Myeloma Patients Have the Best Outcomes? New Study Shows Key Findings.Aug 06, 2020
Belantamab Mafodotin Teams with SpringWorks Drug to Increase BCMA Expression in Early Myeloma TrialAug 04, 2020
Reflexiones Luego De Diez Años Del Diagnóstico De MielomaAug 04, 2020
Conquer Magazine: How Real-World Evidence Has the Potential to Shape Real-World Outcomes in Multiple MyelomaJul 30, 2020
Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Study Myeloma Genetics and Drug ResistanceJul 30, 2020- Reflections on Ten Years With a Myeloma DiagnosisJul 24, 2020
How Long Does COVID-19 Immunity Last?Jul 11, 2020
HealthTree Research: The Intersection of Psoriasis and Multiple MyelomaJul 08, 2020
The Power of Our Cancer StoriesJun 30, 2020
Remisión en el Mieloma MúltipleJun 26, 2020
La dexametasona mejora los resultados en los casos graves de COVID-19 (sólo en pacientes con respiradores u oxígeno) según un estudio de la Universidad de OxfordJun 26, 2020
HealthTree University: Multiple Myeloma Basics Part 1 (3 of 3)Jun 25, 2020
ASCO 2020: CELMoDs as a New Drug Class in Multiple MyelomaJun 18, 2020
HealthTree Webinar: Track My MyelomaJun 17, 2020
¿Es Genético el Mieloma Múltiple?Jun 13, 2020
HealthTree University: Multiple Myeloma Basics Part 1 (1 of 3)Jun 04, 2020
ASCO 2020: Various Approaches for Smoldering MyelomaMay 29, 2020
